These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10932029)

  • 1. Overview of the prospective randomized evaluation of the vascular effects of Norvasc (amlodipine) trial: PREVENT.
    Mancini GB
    Can J Cardiol; 2000 Jul; 16 Suppl D():5D-7D. PubMed ID: 10932029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of calcium antagonists on atherosclerosis progression and intima media thickness].
    Zannad F
    Drugs; 2000; 59 Spec No 2():39-46. PubMed ID: 11002857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive therapy and regression of coronary artery disease: insights from the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis (CAMELOT) and Norvasc for Regression of Manifest Atherosclerotic Lesions by Intravascular Sonographic Evaluation (NORMALISE) trials.
    Brener SJ; Ivanc TB; Poliszczuk R; Chen M; Tuzcu EM; Hu T; Frid DJ; Nissen SE
    Am Heart J; 2006 Dec; 152(6):1059-63. PubMed ID: 17161053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of inter-individual blood pressure variability on the progression of atherosclerosis in carotid and coronary arteries: a post hoc analysis of the NORMALISE and PREVENT studies.
    Kim JS; Park S; Yan P; Jeffers BW; Cerezo C
    Eur Heart J Cardiovasc Pharmacother; 2017 Apr; 3(2):82-89. PubMed ID: 27533954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary angiographic changes in patients with cardiac events in the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT).
    Mancini GB; Pitt B
    Am J Cardiol; 2002 Oct; 90(7):776-8. PubMed ID: 12356398
    [No Abstract]   [Full Text] [Related]  

  • 7. Post hoc analysis of coronary findings from the prospective randomized evaluation of the vascular effects of the Norvasc trial (PREVENT).
    Mancini GB; Miller ME; Evans GW; Byington R; Furberg CD; Pitt B;
    Am J Cardiol; 2002 Jun; 89(12):1414-6. PubMed ID: 12062738
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators.
    Pitt B; Byington RP; Furberg CD; Hunninghake DB; Mancini GB; Miller ME; Riley W
    Circulation; 2000 Sep; 102(13):1503-10. PubMed ID: 11004140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost-effectiveness evaluation of amlodipine usage in patients with coronary artery disease in Sweden.
    Doyle JJ; McGuire A; Arocho R; Arikian S; Casciano J; Svangren P; Casciano R; Kim R; Kugel H
    Int J Clin Pract; 2002 Mar; 56(2):76-81. PubMed ID: 11926709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale, design, and baseline characteristics of the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT).
    Byington RP; Miller ME; Herrington D; Riley W; Pitt B; Furberg CD; Hunninghake DB; Mancini GB
    Am J Cardiol; 1997 Oct; 80(8):1087-90. PubMed ID: 9352986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacoeconomic impact of amlodipine use on coronary artery disease.
    De Portu S; Menditto E; Scalone L; Bustacchini S; Cricelli C; Mantovani LG
    Pharmacol Res; 2006 Aug; 54(2):158-63. PubMed ID: 16814560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of amlodipine on ischemia after percutaneous transluminal coronary angioplasty: secondary results of the Coronary Angioplasty Amlodipine Restenosis (CAPARES) Study.
    Jørgensen B; Thaulow E;
    Am Heart J; 2003 Jun; 145(6):1030-5. PubMed ID: 12796759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events].
    Eleuteri E
    Ital Heart J Suppl; 2001 Jan; 2(1):85-6. PubMed ID: 11216089
    [No Abstract]   [Full Text] [Related]  

  • 14. Confusing Press Releases and the PREVENT Study.
    Messerli FH
    Circulation; 2001 Oct; 104(18):E95. PubMed ID: 11684643
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions that beneficially influence the evolution of coronary atherosclerosis. The case for calcium channel blockers.
    Waters D; Lespérance J
    Circulation; 1992 Dec; 86(6 Suppl):III111-6. PubMed ID: 1424044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium antagonists and atherosclerosis protection in hypertension.
    Hernández RH; Armas-Hernández MJ; Velasco M; Israili ZH; Armas-Padilla MC
    Am J Ther; 2003; 10(6):409-14. PubMed ID: 14624278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Is regression of coronary sclerosis possible?].
    Krayenbühl HP
    Schweiz Rundsch Med Prax; 1993 Nov; 82(47):1348-53. PubMed ID: 8272700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of effects of amlodipine and angiotensin receptor blockers on the intima-media thickness of carotid arterial wall (AAA study: amlodipine vs. ARB in atherosclerosis study).
    Ikeda H; Minamikawa J; Nakamura Y; Honjo S; Hamamoto Y; Wada Y; Nabe K; Koshiyama H
    Diabetes Res Clin Pract; 2009 Jan; 83(1):50-3. PubMed ID: 19070383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.